These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24046941)

  • 1. Physicochemical compatibility of nebulizable drug admixtures containing budesonide and colistimethate or hypertonic saline.
    Klemmer A; Krämer I; Kamin W
    Int J Pharm Compd; 2013; 17(3):254-61. PubMed ID: 24046941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physicochemical compatibility of nebulizable drug admixtures containing colistimethate and tobramycin.
    Wollstadt A; Krämer I; Kamin W
    Pharmazie; 2013 Sep; 68(9):744-8. PubMed ID: 24147342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compatibility and aerosol characteristics of formoterol fumarate mixed with other nebulizing solutions.
    Akapo S; Gupta J; Martinez E; McCrea C; Ye L; Roach M
    Ann Pharmacother; 2008 Oct; 42(10):1416-24. PubMed ID: 18780805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhalation solutions: which one are allowed to be mixed? Physico-chemical compatibility of drug solutions in nebulizers.
    Kamin W; Schwabe A; Krämer I
    J Cyst Fibros; 2006 Dec; 5(4):205-13. PubMed ID: 16678502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physicochemical compatibility and stability of nebulizable drug admixtures containing Dornase alfa and tobramycin.
    Klemmer A; Krämer I; Kamin W
    Pulm Pharmacol Ther; 2014 Jun; 28(1):53-59. PubMed ID: 24035821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compatibility of budesonide inhalation suspension with four nebulizing solutions.
    McKenzie JE; Cruz-Rivera M
    Ann Pharmacother; 2004 Jun; 38(6):967-72. PubMed ID: 15084687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical and physical compatibility of levalbuterol inhalation solution concentrate mixed with budesonide, ipratropium bromide, cromolyn sodium, or acetylcysteine sodium.
    Bonasia PJ; McVicar WK; Bill W; Ong S
    Respir Care; 2008 Dec; 53(12):1716-22. PubMed ID: 19025708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compatibility of cisplatin and fluorouracil in 0.9% sodium chloride injection.
    Stewart CF; Fleming RA
    Am J Hosp Pharm; 1990 Jun; 47(6):1373-7. PubMed ID: 2368735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compatibility and stability of ternary admixtures of morphine with haloperidol or midazolam and dexamethasone or methylprednisolone.
    Vermeire A; Remon JP
    Int J Pharm; 1999 Jan; 177(1):53-67. PubMed ID: 10205603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aerosol characteristics of admixture of budesonide inhalation suspension with a beta2-agonist, procaterol.
    Itazawa T; Adachi Y; Ito Y; Higuchi O; Mochizuki H; Shimojo N; Inoue T
    Allergol Int; 2013 Mar; 62(1):131-5. PubMed ID: 23348859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicochemical compatibility of nebulizable drug mixtures containing dornase alfa and ipratropium and/or albuterol.
    Krämer I; Schwabe A; Lichtinghagen R; Kamin W
    Pharmazie; 2007 Oct; 62(10):760-6. PubMed ID: 18236781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compatibility of aminophylline and methylprednisolone sodium succinate intravenous admixtures.
    Johnson CE; Cohen IA; Craft DA; Lizer MH
    Am J Hosp Pharm; 1986 Jun; 43(6):1482-5. PubMed ID: 3524206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visual compatibility of common nebulizer medications with 7% sodium chloride solution.
    Fox LM; Foushee JA; Jackson DJ; Watson H
    Am J Health Syst Pharm; 2011 Jun; 68(11):1032-5. PubMed ID: 21593232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical compatibility of cefmetazole sodium with ranitidine hydrochloride during simulated Y-site administration.
    Inagaki K; Gill MA; Okamoto MP; Takagi J
    J Parenter Sci Technol; 1993; 47(1):35-9. PubMed ID: 8445498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compatibility of clindamycin phosphate with cefotaxime sodium or netilmicin sulfate in small-volume admixtures.
    Foley PT; Bosso JA; Bair JN; Townsend RJ
    Am J Hosp Pharm; 1985 Apr; 42(4):839-43. PubMed ID: 4014236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compatibility of ciprofloxacin injection with selected drugs and solutions.
    Goodwin SD; Nix DE; Heyd A; Wilton JH
    Am J Hosp Pharm; 1991 Oct; 48(10):2166-71. PubMed ID: 1781473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of cisplatin and etoposide in intravenous admixtures.
    Stewart CF; Hampton EM
    Am J Hosp Pharm; 1989 Jul; 46(7):1400-4. PubMed ID: 2757048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compatibility of arformoterol tartrate inhalation solution with three nebulized drugs.
    Bonasia P; Cook C; Cheng Y; Ong S
    Curr Med Res Opin; 2007 Oct; 23(10):2477-83. PubMed ID: 17784997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compatibility of heparin sodium and morphine sulfate.
    Baker DE; Yost GS; Craig VL; Campbell RK
    Am J Hosp Pharm; 1985 Jun; 42(6):1352-5. PubMed ID: 4014252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability and compatibility of methylprednisolone sodium succinate and cimetidine hydrochloride in 5% dextrose injection.
    Strom JG; Miller SW
    Am J Hosp Pharm; 1991 Jun; 48(6):1237-41. PubMed ID: 1858803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.